Product References
Flexible Cyclic Immunofluorescence (cyCIF) Using Oligonucleotide Barcoded Antibodies.
Cancers
McMahon NP,Jones JA,Anderson AN,Dietz MS,Wong MH,Gibbs SL
MA5-13675 was used in Flow Cytometry, Immunocytochemistry, Immunohistochemistry, Immunoprecipitation, Western Blot to generate highly multiplexed images.
Sun Jan 29 00:00:00 UTC 2023
Expression and Clinical Significance of HER2 Gene and DNMT1 in Non-Small-Cell Lung Cancer.
Disease markers
Diao W,Ding C,Yuan B,Li Z,Sun N,Huang J
Published figure using ErbB2 (HER-2) monoclonal antibody (Product # MA5-13675) in Immunohistochemistry
Wed Aug 24 00:00:00 UTC 2022
Aberrant Neuregulin 1/ErbB Signaling in Charcot-Marie-Tooth Type 4D Disease.
Molecular and cellular biology
Jiang LT,Chen YH,Huang JH,Tong WF,Jin LJ,Li LX
MA5-13675 was used in Western Blotting to suggest that the demyelinating phenotype of Charcot-Marie-Tooth type 4D (CMT4D) disease is at least in part a consequence of molecular defects in neuregulin 1/ErbB signaling.
Thu Jul 21 00:00:00 UTC 2022
Excessive All-Trans Retinoic Acid Inhibits Cell Proliferation Through Upregulated MicroRNA-4680-3p in Cultured Human Palate Cells.
Frontiers in cell and developmental biology
Yoshioka H,Ramakrishnan SS,Shim J,Suzuki A,Iwata J
Published figure using ErbB2 (HER-2) monoclonal antibody (Product # MA5-13675) in Immunocytochemistry
Wed Feb 17 00:00:00 UTC 2021
Excessive All-Trans Retinoic Acid Inhibits Cell Proliferation Through Upregulated MicroRNA-4680-3p in Cultured Human Palate Cells.
Frontiers in cell and developmental biology
Yoshioka H,Ramakrishnan SS,Shim J,Suzuki A,Iwata J
Published figure using ErbB2 (HER-2) monoclonal antibody (Product # MA5-13675) in Immunocytochemistry
Wed Feb 17 00:00:00 UTC 2021
Excessive All-Trans Retinoic Acid Inhibits Cell Proliferation Through Upregulated MicroRNA-4680-3p in Cultured Human Palate Cells.
Frontiers in cell and developmental biology
Yoshioka H,Ramakrishnan SS,Shim J,Suzuki A,Iwata J
Published figure using ErbB2 (HER-2) monoclonal antibody (Product # MA5-13675) in Immunocytochemistry
Wed Feb 17 00:00:00 UTC 2021
Excessive All-Trans Retinoic Acid Inhibits Cell Proliferation Through Upregulated MicroRNA-4680-3p in Cultured Human Palate Cells.
Frontiers in cell and developmental biology
Yoshioka H,Ramakrishnan SS,Shim J,Suzuki A,Iwata J
Published figure using ErbB2 (HER-2) monoclonal antibody (Product # MA5-13675) in Immunocytochemistry
Wed Feb 17 00:00:00 UTC 2021
Phosphorylation of STAT3 and ERBB2 mediates hypoxia‑induced VEGF release in ARPE‑19 cells.
Molecular medicine reports
Hwang S,Seong H,Ryu J,Jeong JY,Kang TS,Nam KY,Seo SW,Kim SJ,Kang SS,Han YS
MA5-13675 was used in Western Blot to investigate if inhibition of erbB‚2 receptor tyrosine kinase 2 and signal transducer and activator of transcription 3‚mediated pathways under hypoxia may represent a new strategy for treating retinal vascular disease.
Thu Oct 01 00:00:00 UTC 2020
Phosphorylation of STAT3 and ERBB2 mediates hypoxia‑induced VEGF release in ARPE‑19 cells.
Molecular medicine reports
Hwang S,Seong H,Ryu J,Jeong JY,Kang TS,Nam KY,Seo SW,Kim SJ,Kang SS,Han YS
MA5-13675 was used in Western Blot to investigate if inhibition of erbB‚2 receptor tyrosine kinase 2 and signal transducer and activator of transcription 3‚mediated pathways under hypoxia may represent a new strategy for treating retinal vascular disease.
Thu Oct 01 00:00:00 UTC 2020
Detection and analysis of multiple biomarkers in ovarian cancer: clinical significance in diagnosis, treatment, and prognosis evaluation.
Gland surgery
Ji R,Li Y,He C,Zhu X,He A,Lu Y
MA5-13675 was used in Immunohistochemistry (Paraffin) to explore the clinical significance of CA125, CK7, CK20, ER, PR, C-erbb2, and P-gp in ovarian cancer.
Tue Dec 01 00:00:00 UTC 2020
An HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse Model.
Vaccines
Nika L,Cuadrado-Castano S,Asthagiri Arunkumar G,Grünwald-Gruber C,McMahon M,Koczka K,García-Sastre A,Krammer F,Grabherr R
Published figure using ErbB2 (HER-2) monoclonal antibody (Product # MA5-13675) in ELISA
Mon May 20 00:00:00 UTC 2019
An HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse Model.
Vaccines
Nika L,Cuadrado-Castano S,Asthagiri Arunkumar G,Grünwald-Gruber C,McMahon M,Koczka K,García-Sastre A,Krammer F,Grabherr R
Published figure using ErbB2 (HER-2) monoclonal antibody (Product # MA5-13675) in ELISA
Mon May 20 00:00:00 UTC 2019
Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival.
Breast cancer research : BCR
Yardley DA,Kaufman PA,Huang W,Krekow L,Savin M,Lawler WE,Zrada S,Starr A,Einhorn H,Schwartzberg LS,Adams JW,Lie Y,Paquet AC,Sperinde J,Haddad M,Anderson S,Brigino M,Pesano R,Bates MP,Weidler J,Bosserman L
MA5-13675 was used in immunohistochemistry to determine the best method to assess HER2 status in breast cancer samples
Wed Mar 18 00:00:00 UTC 2015
Impedance spectroscopy assisted by magnetic nanoparticles as a potential biosensor principle for breast cancer cells in suspension.
Physiological measurement
Silva JG,Cárdenas RA,Quiróz AR,Sánchez V,Lozano LM,Pérez NM,López J,Villanueva C,González CA
MA5-13675 was used in ELISA to study the use of impedence spectroscopy combined with magnetic nanoparticles for the measurement of beast cancer cells in suspension
Sun Jun 01 00:00:00 UTC 2014
Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Janjigian YY,Viola-Villegas N,Holland JP,Divilov V,Carlin SD,Gomes-DaGama EM,Chiosis G,Carbonetti G,de Stanchina E,Lewis JS
MA5-13675 was used in western blot to study the pharmacodynamics of afatinib in HER2-positive gastric cancer using PET
Sat Jun 01 00:00:00 UTC 2013
A cell-based screening system for influenza A viral RNA transcription/replication inhibitors.
Scientific reports
Ozawa M,Shimojima M,Goto H,Watanabe S,Hatta Y,Kiso M,Furuta Y,Horimoto T,Peters NR,Hoffmann FM,Kawaoka Y
MA5-13675 was used in western blot to develop a cell-based screening system to identify compounds that inhibit influenza A viral RNA transcription/replication
Mon Sep 30 00:00:00 UTC 2013
HER2/neu gene amplification and protein overexpression in gastric and gastroesophageal junction adenocarcinoma: a review of histopathology, diagnostic testing, and clinical implications.
Archives of pathology & laboratory medicine
Hechtman JF,Polydorides AD
MA5-13675 was used in immunohistochemistry to review the literature on HER2/neu gene amplification and protein overexpression in gastric and gastroesophageal junction adenocarcinoma
Fri Jun 01 00:00:00 UTC 2012
Clinicopathologic features of the mixed epithelial and mesenchymal type metaplastic breast carcinoma with myoepithelial differentiation in a subset of six cases.
Pathology, research and practice
Yigit S,Pehlivan FS,Evcim G,Etit D
MA5-13675 was used in immunohistochemistry to study six cases of mixed epithelial and mesenchymal type metaplastic breast carcinoma with myoepithelial differentiation
Thu Mar 15 00:00:00 UTC 2012
Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.
Pathology oncology research : POR
El-Gendi SM,Mostafa MF,El-Gendi AM
MA5-13675 was used in immunohistochemistry to study the prognostic value of stromal caveolin-1 in breast cancer
Sun Apr 01 00:00:00 UTC 2012
Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action.
Breast cancer research : BCR
DeFazio-Eli L,Strommen K,Dao-Pick T,Parry G,Goodman L,Winslow J
MA5-13675 was used in immunoprecipitation to investigate the state of HER1-HER2 interaction and modification in cell lines and tumors
Fri Apr 15 00:00:00 UTC 2011
Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression.
Cancer prevention research (Philadelphia, Pa.)
de Assis S,Warri A,Benitez C,Helferich W,Hilakivi-Clarke L
MA5-13675 was used in western blot to study the role of BRCA-1 in the protective effects of prepubertal genistein against mammary tumorigenesis
Thu Sep 01 00:00:00 UTC 2011
Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
British journal of neurosurgery
Abdelzaher E,El-Gendi SM,Yehya A,Gowil AG
MA5-13675 was used in immunohistochemistry to identify biomarkers that predict the recurrence of benign meningiomas
Thu Dec 01 00:00:00 UTC 2011
Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
Cancer
Krishnamurthy S,Cristofanilli M,Singh B,Reuben J,Gao H,Cohen EN,Andreopoulou E,Hall CS,Lodhi A,Jackson S,Lucci A
MA5-13675 was used in immunohistochemistry to study the presence of circulating tumor cells in blood and disseminated tumor cells in bone marrow of women with early stage breast cancer
Thu Jul 15 00:00:00 UTC 2010
Glioma cells display complex cell surface topographies that resist the actions of cytolytic effector lymphocytes.
Journal of immunology (Baltimore, Md. : 1950)
Hoa N,Ge L,Kuznetsov Y,McPherson A,Cornforth AN,Pham JT,Myers MP,Ahmed N,Salsman VS,Lamb LS,Bowersock JE,Hu Y,Zhou YH,Jadus MR
MA5-13675 was used in immunocytochemistry to study the mechanisms by which glioma cells evade the actions of cytolytic effector lymphocytes
Fri Oct 15 00:00:00 UTC 2010
Comparison of central HER2 testing with quantitative total HER2 expression and HER2 homodimer measurements using a novel proximity-based assay.
American journal of clinical pathology
Huang W,Reinholz M,Weidler J,Yolanda L,Paquet A,Whitcomb J,Lingle W,Jenkins RB,Chen B,Larson JS,Tan Y,Sherwood T,Bates M,Perez EA
MA5-13675 was used in ELISA to develop and evaluate a novel proximity-based assay for quantitating total HER2 expression and HER2 homodimer
Sun Aug 01 00:00:00 UTC 2010
Protein expression profiling of primary mammary epithelial cells derived from MMTV-neu mice revealed that HER2/NEU-driven changes in protein expression are functionally clustered.
IUBMB life
Park S,Lee KM,Ju JH,Kim J,Noh DY,Lee T,Shin I
MA5-13675 was used in western blot to profile protein expression in primary mammary epithelial cells derived from MMTV-neu mice to identify novel biomarkers of tumorigenesis
Fri Jan 01 00:00:00 UTC 2010
Low Level of Her-2 Locus Amplification by Fluorescent In Situ Hybridization Does Not Correlate with Her-2 Protein Overexpression by Immunohistochemistry in Barrett's Esophagus.
Journal of oncology
Rygiel AM,Milano F,Ten Kate FJ,Bergman JJ,Krishnadath KK
MA5-13675 was used in immunohistochemistry to study the correlation of Her-2 locus amplification with Her-2 protein overexpression in patients with Barrett's esophagus and esophageal adenocarcinoma
Thu Jul 14 00:00:00 UTC 2011
Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial.
Journal of translational medicine
Norell H,Poschke I,Charo J,Wei WZ,Erskine C,Piechocki MP,Knutson KL,Bergh J,Lidbrink E,Kiessling R
MA5-13675 was used in immunohistochemistry to study the therapeutic potential of HER-2/neu vaccination plus low doses of GM-CSF and IL-2 in metastatic breast carcinoma
Mon Jun 07 00:00:00 UTC 2010
Interaction of syndecan and alpha6beta4 integrin cytoplasmic domains: regulation of ErbB2-mediated integrin activation.
The Journal of biological chemistry
Wang H,Leavitt L,Ramaswamy R,Rapraeger AC
MA5-13675 was used in immunoprecipitation and western blot to demonstrate that the beta4-dependent signaling in human squamous carcinoma cells is dependent on the syndecan family of matrix receptors
Fri Apr 30 00:00:00 UTC 2010
Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
Journal of cancer research and clinical oncology
Strumane K,Rygiel T,van der Valk M,Collard JG
MA5-13675 was used in western blot to study the role of tiam1 in mammary tumor formation in MMTV-c-neu and MMTV-c-myc mice
Thu Jan 01 00:00:00 UTC 2009
HER-2/neu (c-erbB-2) oncoprotein in hyperplastic endometrial polyps detected in two cats.
Journal of feline medicine and surgery
Misirlioglu D,Nak D,Ozyigit MO,Nak Y,Akkoc A
MA5-13675 was used in immunohistochemistry to study the HER-2/neu (c-erbB-2) oncoprotein in hyperplastic endometrial polyps detected in two cats
Thu Oct 01 00:00:00 UTC 2009
Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
Cancer prevention research (Philadelphia, Pa.)
Hakim AA,Barry CP,Barnes HJ,Anderson KE,Petitte J,Whitaker R,Lancaster JM,Wenham RM,Carver DK,Turbov J,Berchuck A,Kopelovich L,Rodriguez GC
MA5-13675 was used in immunohistochemistry to investigate the similar changes of p53, ras, and HER-2/neu genes in ovatian adenocarcinomas between chicken and human
Sun Feb 01 00:00:00 UTC 2009
Trastuzumab activates allogeneic or autologous antibody-dependent cellular cytotoxicity against malignant rhabdoid tumor cells and interleukin-2 augments the cytotoxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research
Katsumi Y,Kuwahara Y,Tamura S,Kikuchi K,Otabe O,Tsuchiya K,Iehara T,Kuroda H,Hosoi H,Sugimoto T
MA5-13675 was used in immunocytochemistry to investigate the mechanism for the malignant rhabdoid tumor treatment with trastuzumab
Fri Feb 15 00:00:00 UTC 2008
Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism.
Proteins
Hu S,Zhu Z,Li L,Chang L,Li W,Cheng L,Teng M,Liu J
MA5-13675 was used in western blot to study the tumor inhibitory mechanism of an anti-ErbB2 antibody
Fri Feb 15 00:00:00 UTC 2008
Loss of annexin A1 expression in breast cancer progression.
Applied immunohistochemistry & molecular morphology : AIMM
Cao Y,Li Y,Edelweiss M,Arun B,Rosen D,Resetkova E,Wu Y,Liu J,Sahin A,Albarracin CT
MA5-13675 was used in immunohistochemistry to study ANXA1 expression during the progression of breast carcinomas
Mon Dec 01 00:00:00 UTC 2008
Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Schmidt MK,Tollenaar RA,de Kemp SR,Broeks A,Cornelisse CJ,Smit VT,Peterse JL,van Leeuwen FE,Van't Veer LJ
MA5-13675 was used in immunohistochemistry to study breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation
Mon Jan 01 00:00:00 UTC 2007
Anti-EGFR and ErbB-2 antibodies attenuate cyclooxygenase-2 expression and cooperatively inhibit survival of human colon cancer cells.
Cancer letters
Half E,Sun Y,Sinicrope FA
MA5-13675 was used in western blot to examine the effect of anti-EGFR and ErbB-2 antibodies on the survival of human colon cancer cells
Thu Jun 28 00:00:00 UTC 2007
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.
Breast cancer research : BCR
Kreike B,van Kouwenhove M,Horlings H,Weigelt B,Peterse H,Bartelink H,van de Vijver MJ
MA5-13675 was used in immunohistochemistry to study triple negative breast carcinoma histopathology and gene expression patterns in order to define clinically significant sub-groups
Tue Mar 11 00:00:00 UTC 2008
Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.
Cancer
Mazouni C,Hall A,Broglio K,Fritsche H,Andre F,Esteva FJ,Hortobagyi GN,Buzdar AU,Pusztai L,Cristofanilli M
MA5-13675 was used in immunohistochemistry to study the value of serum HER-2 receptor extracellular domain measurements for predicting the response to chemotherapy in primary breast cancer patients
Thu Feb 01 00:00:00 UTC 2007
Primary neuroendocrine carcinoma of the breast: a case report.
Tumori
Yaren A,Kelten C,Akbulut M,Teke Z,Duzcan E,Erdem E
MA5-13675 was used in immunohistochemistry to report on a case of primary neuroendocrine carcinoma of the breast
Tue Dec 11 00:00:00 UTC 2007
Abundance and localization of skeletal muscle-related erbB2 may stimulate tumour growth during initial stages of oral oncogenesis.
Journal of musculoskeletal & neuronal interactions
Vairaktaris E,Moulavassili P,Loukeri S,Spyridonidou S,Yapijakis C,Vassiliou S,Nkenke E,Vylliotis A,Papakosta V,Lazaris A,Patsouris E
MA5-13675 was used in immunohistochemistry to study the role of skeletal muscle-related erbB2 in stimulating tumor growth in oral oncogenesis
Wed Oct 17 00:00:00 UTC 2007
EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt.
Neoplasia (New York, N.Y.)
Martín-Orozco RM,Almaraz-Pro C,Rodríguez-Ubreva FJ,Cortés MA,Ropero S,Colomer R,López-Ruiz P,Colás B
MA5-13675 was used in western blot to investigate the impact of epidermal growth factor on neuroendocrine differentiation of LNCaP cells
Wed Aug 01 00:00:00 UTC 2007
Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
Cancer research
Shyamala G,Chou YC,Cardiff RD,Vargis E
MA5-13675 was used in immunohistochemistry to study the effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells
Wed Nov 01 00:00:00 UTC 2006
Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker.
The American journal of surgical pathology
Skálová A,Gnepp DR,Simpson RH,Lewis JE,Janssen D,Sima R,Vanecek T,Di Palma S,Michal M
MA5-13675 was used in immunohistochemistry to investigate clonality of sclerosing polycystic adenosis by human androgen receptor polymorphism
Tue Aug 01 00:00:00 UTC 2006
MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC).
Pathology, research and practice
Karg A,Dinç ZA,Başok O,Uçvet A
MA5-13675 was used in immunohistochemistry to study the expression of MUC4 in different stages of non-small cell lung cancer and its relationship with ErbB2 expression
Thu Sep 21 00:00:00 UTC 2006
Gene targeting of ErbB3 using a Cre-mediated unidirectional DNA inversion strategy.
Genesis (New York, N.Y. : 2000)
Qu S,Rinehart C,Wu HH,Wang SE,Carter B,Xin H,Kotlikoff M,Arteaga CL
MA5-13675 was used in western blot to study the efficacy of gene targeting of ErbB3 using an in vivo recombination unidirectional DNA inversion technology
Sun Oct 01 00:00:00 UTC 2006
[An analysis of genetic transmission in a father and son with osteosarcoma].
Acta orthopaedica et traumatologica turcica
Tokatli F,Alas RC,Altaner S,Pala F,Uygun K,Uzal C,Yalniz E
MA5-13675 was used in immunohistochemistry to report on a case of a father and son with familial osteosarcoma
Fri Jul 20 00:00:00 UTC 2007
Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.
Histopathology
Di Palma S,Skálová A,Vanìèek T,Simpson RH,Stárek I,Leivo I
MA5-13675 was used in immunohistochemistry to characterize non-invasive carcinoma ex pleomorphic adenoma through HER-2/neu and MIB1 expression
Tue Feb 01 00:00:00 UTC 2005
Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.
Histopathology
Skalova A,Ryska A,Kajo K,Di Palma S,Kinkor Z,Michal M
MA5-13675 was used in immunohistochemistry to report the clinical cases of cystic hypersecretory carcinoma
Sat Jan 01 00:00:00 UTC 2005
Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells.
The Journal of steroid biochemistry and molecular biology
Stewart LV,Lyles B,Lin MF,Weigel NL
MA5-13675 was used in western blot to study the effects of vitamin D receptor agonists on androgen-dependent LNCaP human prostate cancer cell growth
Sat Oct 01 00:00:00 UTC 2005
Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.
Breast cancer research : BCR
Lenferink AE,Magoon J,Cantin C,O'Connor-McCourt MD
MA5-13675 was used in immunoprecipitation to study three novel mouse mammary tumor cell lines for use in TGF-beta and Neu pathway signaling studies
Tue Oct 05 00:00:00 UTC 2004
Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Carcinogenesis
Zinser GM,Welsh J
MA5-13675 was used in immunohistochemistry to study the effect of vitamin D receptor gene dosage on mammary gland morphology and tumorigenesis
Wed Dec 01 00:00:00 UTC 2004
Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer: early assessment predicts clinical response.
Clinical cancer research : an official journal of the American Association for Cancer Research
Davis DW,Buchholz TA,Hess KR,Sahin AA,Valero V,McConkey DJ
MA5-13675 was used in immunohistochemistry to study whether early assessment of apoptosis following breast cancer neoadjuvant chemotherapy predicts clinical response
Sat Mar 01 00:00:00 UTC 2003
Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research
Verschraegen CF,Hu W,Du Y,Mendoza J,Early J,Deavers M,Freedman RS,Bast RC,Kudelka AP,Kavanagh JJ,Giovanella BC
MA5-13675 was used in immunocytochemistry to characterize cell cultures and xenografts derived from patients with ovarian cancer
Sat Feb 01 00:00:00 UTC 2003
Profiling receptor tyrosine kinase activation by using Ab microarrays.
Proceedings of the National Academy of Sciences of the United States of America
Nielsen UB,Cardone MH,Sinskey AJ,MacBeath G,Sorger PK
MA5-13675 was used in ELISA to study the receptor tyrosine kinase activation by through antibody microarrays
Tue Aug 05 00:00:00 UTC 2003
Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
Cancer
Middleton LP,Amin M,Gwyn K,Theriault R,Sahin A
MA5-13675 was used in immunohistochemistry to study the histopathology and immunohistochemistry of breast carcinoma in pregnant women
Mon Sep 01 00:00:00 UTC 2003
Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases.
The American journal of surgical pathology
Simpson RH,Prasad AR,Lewis JE,Skálová A,David L
MA5-13675 was used in immunohistochemistry to study the clinicopathology and immunohistochemistry of four cases of mucin-rich variant of salivary duct carcinoma
Fri Aug 01 00:00:00 UTC 2003
A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses.
Journal of immunology (Baltimore, Md. : 1950)
Dakappagari NK,Pyles J,Parihar R,Carson WE,Young DC,Kaumaya PT
MA5-13675 was used in western blot to develop and evaluate a multi-epitope vaccine targeting HER-2
Tue Apr 15 00:00:00 UTC 2003
Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease.
Virchows Archiv : an international journal of pathology
Kremser R,Obrist P,Spizzo G,Erler H,Kendler D,Kemmler G,Mikuz G,Ensinger C
MA5-13675 was used in immunohistochemistry to study the prognostic value of Her2/neu overexpression in differentiated thyroid carcinomas
Tue Apr 01 00:00:00 UTC 2003
Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope.
Peptides
Lucchese A,Stevanovic S,Sinha AA,Mittelman A,Kanduc D
MA5-13675 was used in western blot to study whether it is possible to predict which peptides will evoke a humoral immune response using the human HER-2/neu breast cancer-associated antigen as a model
Sat Feb 01 00:00:00 UTC 2003
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Cancer research
Half E,Tang XM,Gwyn K,Sahin A,Wathen K,Sinicrope FA
MA5-13675 was used in immunohistochemistry to study the expression of COX-2 in human breast cancers and adjacent ductal carcinoma in situ
Fri Mar 15 00:00:00 UTC 2002
Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteome.
International journal of cancer
Mittelman A,Lucchese A,Sinha AA,Kanduc D
MA5-13675 was used in western blot to study the immune response to EC HER-2/NEU peptides not shared by the host's proteome
Wed Apr 10 00:00:00 UTC 2002
Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
Human pathology
Van Eeden S,Quaedvlieg PF,Taal BG,Offerhaus GJ,Lamers CB,Van Velthuysen ML
MA5-13675 was used in immunohistochemistry to study whether refining the grading of low-grade neuroendocrine tumors of the midgut and unknown origin is of prognostic/predictive value
Fri Nov 01 00:00:00 UTC 2002
Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2.
Cancer research
Murillo H,Schmidt LJ,Tindall DJ
MA5-13675 was used in western blot to study the role of p38 MAP kinase in the induction of apoptosis in androgen-independent prostate cancer cells by the EGFR inhibitor typhostin AG825
Mon Oct 15 00:00:00 UTC 2001
The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.
Cancer research
Moasser MM,Basso A,Averbuch SD,Rosen N
MA5-13675 was used in western blot to study the inhibition of HER2-driven signaling and growth suppression of HER2-overexpressing tumor cells by Iressa
Mon Oct 01 00:00:00 UTC 2001
